Cargando…
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19
Increasing evidence points to endothelial cell dysfunction as a key pathophysiological factor in severe coronavirus disease-19 (COVID-19), manifested by platelet aggregation, microthrombi and altered vasomotor tone. This may be driven by direct endothelial cell entry by the virus, or indirectly by a...
Autores principales: | Whyte, Martin B., Vas, Prashanth, Heiss, Christian, Feher, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217793/ https://www.ncbi.nlm.nih.gov/pubmed/32451317 http://dx.doi.org/10.1016/j.diabres.2020.108217 |
Ejemplares similares
-
Diabetes, obesity and COVID‐19: A complex interplay
por: Vas, Prashanth, et al.
Publicado: (2020) -
Microvascular disease in diabetes and severe COVID-19 outcomes
por: Corcillo, Antonella, et al.
Publicado: (2021) -
What is the impact of microvascular complications of diabetes on severe COVID-19?
por: Basra, Ruman, et al.
Publicado: (2022) -
Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?
por: Whyte, Martin Brunel, et al.
Publicado: (2021) -
Diabetic angiopathy and angiogenic defects
por: Xu, Ling, et al.
Publicado: (2012)